Clinical trials in Moldova
142 studies list at least one site in Moldova. 57 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-24.
Status
- Recruiting
- 49
- Active, not recruiting
- 38
- Completed
- 34
- Terminated
- 13
- Enrolling by invitation
- 4
- Not yet recruiting
- 4
Phase
- Phase 1
- 64
- Phase 2
- 61
- Phase 3
- 35
Most studied here
Who runs them
Janssen Research & Development, LLC (6) · AstraZeneca (5) · Vir Biotechnology, Inc. (5) · Gilead Sciences (4) · Sanofi (4) · Celgene (4) · Merck Sharp & Dohme LLC (3) · Regeneron Pharmaceuticals (3)
Studies
Recruiting first, then most recently updated. Showing 50 of 142 — search for more.
- A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDPRecruitingNCT07091630Phase 3
- Bioneer Q-RFIA Clinical EvaluationRecruitingNCT05117788
- A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's DiseaseRecruitingNCT07184944Phase 3
- An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's DiseaseRecruitingNCT07184931Phase 3
- A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's DiseaseRecruitingNCT06226883Phase 2
- A Study of LY3971297 in Participants With Heart FailureRecruitingNCT07547540Phase 1
- A Study to Assess Safety and Efficacy of SOT109 in Patients With Advanced Unresectable or Metastatic Colorectal CancerRecruitingNCT07693751Phase 1/2
- A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast CancerRecruitingNCT06827236Phase 1/2
- Study of XmAb942 in Healthy Participants and Participants With Ulcerative ColitisRecruitingNCT06619990Phase 1/2
- Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBDEnrolling by invitationNCT07652294Phase 2
- DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard ChemoimmunotherapyRecruitingNCT07472517Phase 3
- An Investigational Study of BGB-58067 As a Single Agent and in Combination With Anticancer Agents in Participants With Advanced Solid TumorsRecruitingNCT06589596Phase 1
- REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult ParticipantsRecruitingNCT07213778Phase 3
- A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004)RecruitingNCT07363590Phase 1
- A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell MalignanciesRecruitingNCT05006716Phase 1/2
- BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid TumorsRecruitingNCT06120283Phase 1
- PRIDE III Prison Interventions and HIV Prevention CollaborationRecruitingNCT06962033Not applicable
- Confirmatory Clinical Study in Active Ulcerative ColitisRecruitingNCT07296315Phase 2
- A Study to Assess Safety and Efficacy of SOT106 in Patients With LRRC15-positive Advanced Unresectable or Metastatic Osteosarcoma or Soft Tissue SarcomaNot yet recruitingNCT07801222Phase 1/2
- A Rollover Study for Continued Study Treatment and Ongoing Safety MonitoringEnrolling by invitationNCT06788509Phase 1
- Study of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta VirusRecruitingNCT07096193Phase 1/2
- Validation of Sudden Cardiac Arrest Risk Factors in Patients With CADRecruitingNCT07444931
- A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative ColitisRecruitingNCT07012395Phase 2
- Phase 1 Study to Evaluate Safety and Antiviral Activity of PBGENE-HBV in Adult Patients With Chronic Hepatitis BRecruitingNCT06680232Phase 1
- An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative ColitisRecruitingNCT07184996Phase 3
- Pharmacokinetics, Safety, and Immunogenicity Comparison of Bmab1700 and Opdivo® as Adjuvant Monotherapy in Participants With MelanomaNot yet recruitingNCT07476326Phase 1
- Dose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell MalignanciesRecruitingNCT06980116Phase 1
- A Study to Assess the Safety, Pharmacokinetics, and Efficacy of ABI-6250 in Participants With Chronic Hepatitis D Virus InfectionNot yet recruitingNCT07762027Phase 2
- A Trial of HRS-7085 Tablets in Patients With Moderate to Severe Active Ulcerative ColitisNot yet recruitingNCT07760831Phase 1
- A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)RecruitingNCT07111520Phase 1/2
- A Phase 1b Open-label Study to Evaluate Safety of Plamotamab in Participants With Rheumatoid ArthritisRecruitingNCT07230353Phase 1
- A Study on IB-001 Dose Response and Tolerability in Healthy Adults and Those With Chronic Hepatitis BRecruitingNCT07389044Phase 1
- AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2RecruitingNCT06219941Phase 2
- Study of LFD-200 in Healthy Adults and Adults With Moderate to Severe Rheumatoid ArthritisRecruitingNCT07207954Phase 1
- VIPPSTAR-G1 Digital Early Intervention for Visual ImpairmentNot yet recruitingNCT07717671Not applicable
- A Platform Study in Non-Small Cell Lung Cancer (NSCLC)RecruitingNCT06996782Phase 1/2
- A Phase 2/3 Study on the Efficacy and Safety of Mangaciclanol for Contrast-Enhanced MRI of CNS or Body in Adult PatientsRecruitingNCT07472491Phase 2/3
- Long Term Safety of Alpha1-Proteinase Inhibitor in Subjects With Alpha1 Antitrypsin DeficiencyEnrolling by invitationNCT02796937Phase 3
- A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus ErythematosusRecruitingNCT06613360Phase 1
- A Phase 1/2a Study of WVE-007 in Adults Living With Overweight or ObesityRecruitingNCT06842186Phase 1/2
- Randomized Controlled Trial of a Family-focused Intervention for Caregivers and Young Adolescents (Phase 3 of FLOURISH)RecruitingNCT07240571Not applicable
- A Phase 1 Study of JADE201 in Participants With Rheumatoid ArthritisRecruitingNCT07533955Phase 1
- A Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell CancersRecruitingNCT05910827Phase 1/2
- A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLID TUMORSRecruitingNCT05277168Phase 1/2
- A Study to Assess the Safety and Tolerability of SR-878 in Patients With Rheumatoid ArthritisRecruitingNCT07433335Phase 1
- A Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary TuberculosisRecruitingNCT07209761Phase 3
- A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative ColitisRecruitingNCT06975722Phase 2
- A Long-term Observational Study in Participants Who Have Received PBGENE-HBVEnrolling by invitationNCT07254208
- A Study of MB-001 in Moderately to Severely Active Ulcerative ColitisRecruitingNCT07374471Phase 1/2
- A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel DiseaseRecruitingNCT07113522Phase 2